Home
Charts
Search
Watchlist
Products
Gujarat Themis Biosyn Ltd
·
₹410.05-0.41%Wed, 23 Sept '26
Gujarat Themis Biosyn Ltd
GUJTHEM
BSE
₹410.05
-0.41%
|Wed, 23 Sept '26
SOICxStockScans Reports
Industry
Pharma - API
Indices
View
Documents
Quick Ratios
Edit Ratios
Mkt Cap
Market Capitalization
₹5,364Cr
Close
Close Price
₹412.10
Industry
Industry
Pharma - API
PE
Price To Earnings
114.79
PS
Price To Sales
32.35
Revenue
Revenue
₹166Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—
Quarterly Results
Consolidated
Standalone
Numbers
Percentage
| Quarter | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| 36 | 44 | 44 | |
Growth YoY Revenue Growth YoY% | 22.1 | ||
| 22 | 25 | 23 | |
| 14 | 19 | 21 | |
OPM OPM% | 38.8 | 43.8 | 47.5 |
| 0 | 1 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 2 | 2 |
Depreciation DepreciationCr | 2 | 4 | 4 |
PBT PBTCr | 12 | 14 | 15 |
| 3 | 3 | 4 | |
| 9 | 11 | 11 | |
Growth YoY PAT Growth YoY% | 22.2 | ||
NPM NPM% | 25.3 | 24.6 | 25.3 |
| 0.8 | 1.0 | 1.0 |
| Quarter | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| 36 | 44 | 44 | |
Growth YoY Revenue Growth YoY% | 22.1 | ||
| 22 | 25 | 23 | |
| 14 | 19 | 21 | |
OPM OPM% | 38.8 | 43.8 | 47.5 |
| 0 | 1 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 2 | 2 |
Depreciation DepreciationCr | 2 | 4 | 4 |
PBT PBTCr | 12 | 14 | 15 |
| 3 | 3 | 4 | |
| 9 | 11 | 11 | |
Growth YoY PAT Growth YoY% | 22.2 | ||
NPM NPM% | 25.3 | 24.6 | 25.3 |
| 0.8 | 1.0 | 1.0 |
Profit & Loss
Consolidated
Standalone
Numbers
Percentage
| Financial Year | Mar 2026 |
|---|---|
Revenue RevenueCr | 166 |
Growth Revenue Growth% | |
| 90 | |
| 76 | |
OPM OPM% | 45.5 |
| 2 | |
Interest Expense Interest ExpenseCr | 3 |
Depreciation DepreciationCr | 13 |
PBT PBTCr | 62 |
| 15 | |
PAT PATCr | 47 |
Growth PAT Growth% | |
NPM NPM% | 28.1 |
| 4.3 |
| Financial Year | Mar 2026 |
|---|---|
Revenue RevenueCr | 166 |
Growth Revenue Growth% | |
| 90 | |
| 76 | |
OPM OPM% | 45.5 |
| 2 | |
Interest Expense Interest ExpenseCr | 3 |
Depreciation DepreciationCr | 13 |
PBT PBTCr | 62 |
| 15 | |
PAT PATCr | 47 |
Growth PAT Growth% | |
NPM NPM% | 28.1 |
| 4.3 |
Balance Sheet
Consolidated
Standalone
Numbers
Percentage
| Financial Year |
|---|
Equity Capital Equity CapitalCr |
Reserves ReservesCr |
| Financial Year |
|---|
Equity Capital Equity CapitalCr |
Reserves ReservesCr |
Cash Flow
Consolidated
Standalone
| Financial Year |
|---|
Net Cash Flow Net Cash FlowCr |
Free Cash Flow Free Cash FlowCr |
CFO To PAT CFO To PAT% |
CFO To EBITDA CFO To EBITDA% |
| Financial Year |
|---|
Net Cash Flow Net Cash FlowCr |
Free Cash Flow Free Cash FlowCr |
CFO To PAT CFO To PAT% |
CFO To EBITDA CFO To EBITDA% |
Ratios
Consolidated
Standalone
| Financial Year | Mar 2026 | Current |
|---|---|---|
Market Cap Market CapitalizationCr | 5,364 | |
Price To Earnings Price To Earnings | 114.8 | |
Price To Sales Price To Sales | 32.4 | |
Price To Book Price To Book | 7.1 | |
EV To EBITDA EV To EBITDA | 71.3 | |
GPM GPM% | ||
OPM OPM% | 45.5 | 45.5 |
NPM NPM% | 28.1 | 28.1 |
ROCE ROCE% | ||
ROE ROE% | ||
ROA ROA% | ||
| Financial Year | Mar 2026 | Current |
|---|---|---|
Market Cap Market CapitalizationCr | 5,364 | |
Price To Earnings Price To Earnings | 114.8 | |
Price To Sales Price To Sales | 32.4 | |
Price To Book Price To Book | 7.1 | |
EV To EBITDA EV To EBITDA | 71.3 | |
GPM GPM% | ||
OPM OPM% | 45.5 | 45.5 |
NPM NPM% | 28.1 | 28.1 |
ROCE ROCE% | ||
ROE ROE% | ||
ROA ROA% | ||
Documents — Gujarat Themis Biosyn Ltd
- Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/sy95z2v3uaiyzlgcie3qhs89.pdf
- Q2 FY2024 Earnings Call Transcript (Sep 2023, PDF): https://www.stockscans.in/document/rz5ulhdmf23my4r53pindct3.pdf
- Q4 FY2023 Earnings Call Transcript (Mar 2023, PDF): https://www.stockscans.in/document/ff98yqrgkoyiit3z2rrs56gs.pdf
- Q3 FY2023 Earnings Call Transcript (Dec 2022, PDF): https://www.stockscans.in/document/myfwhzrpl9zb3w8p43qqwqpe.pdf
- Q2 FY2023 Earnings Call Transcript (Sep 2022, PDF): https://www.stockscans.in/document/9pprmt3npvjwsc7b6lxml9u2.pdf
- Q2 FY2022 Earnings Call Transcript (Sep 2021, PDF): https://www.stockscans.in/document/nmbvzxpwgj8e3qvc5kjnfcew.pdf
- Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/pnz8t0kv5teq1vyffwpulxyv.pdf
- Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/61m8cxjbi1avduusm1bj2mdj.pdf
- Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/ufgk8ol9429uki1imvqlwnkk.pdf
- Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/pdd7ol08g64mhwc4vcuwo61t.pdf
- Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/ucd7ma6p9did033ap2apk8ib.pdf
- Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/rwqys0o6nkg1tyeyhsi40468.pdf
- Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/tcakost2lzhx6yatwb8xlzoe.pdf
- Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/nocp90ir05jj0sw9fj6s2uav.pdf
- Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/kt7dandlcmw2mp0keqa7hw2z.pdf
- Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/s28sldguvlk5gubdkww11ujr.pdf
- Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/014cjfx4a7t5p2246xdrbd4e.pdf
- Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/cctif862pn2qf20bbcwbtmk2.pdf
- Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/70yrdp384z4duicd7wpnfj8j.pdf
- Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/rgl97ylp1h9vkhb1m9h5t6z8.pdf
- Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/a3p3r3ieofpbtly01g16g2ge.pdf
- Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/w0mlwd86iwaslt4ensekkdy6.pdf
- FY2026 Annual Report (PDF): https://www.stockscans.in/document/pgyrt86f8r4tei4an6pgdtn8.pdf
- FY2025 Annual Report (PDF): https://www.stockscans.in/document/70cb589fdc3ed1hkmbykmcbp.pdf
- FY2024 Annual Report (PDF): https://www.stockscans.in/document/3yvzz1ottvr3hleue8ypaw0x.pdf
- FY2023 Annual Report (PDF): https://www.stockscans.in/document/t41i8711sg34odftrftlfzlj.pdf
- FY2022 Annual Report (PDF): https://www.stockscans.in/document/3bw2t7nsqllj9zb3m65neczw.pdf
- FY2021 Annual Report (PDF): https://www.stockscans.in/document/36bhugg7dtbxg17qscchxvuw.pdf
- FY2020 Annual Report (PDF): https://www.stockscans.in/document/9gfvqrhpa0j3dyiyx8v804ga.pdf
Concall Transcript Summaries — Gujarat Themis Biosyn Ltd
- Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/BSE%3AGUJTHEM/transcript-notes/202606/sy95z2v3uaiyzlgcie3qhs89.pdf
- Q2 FY2024 Concall Transcript Summary (Sep 2023): https://www.stockscans.in/company/BSE%3AGUJTHEM/transcript-notes/202309/rz5ulhdmf23my4r53pindct3.pdf
- Q4 FY2023 Concall Transcript Summary (Mar 2023): https://www.stockscans.in/company/BSE%3AGUJTHEM/transcript-notes/202303/ff98yqrgkoyiit3z2rrs56gs.pdf
- Q3 FY2023 Concall Transcript Summary (Dec 2022): https://www.stockscans.in/company/BSE%3AGUJTHEM/transcript-notes/202212/myfwhzrpl9zb3w8p43qqwqpe.pdf
- Q2 FY2023 Concall Transcript Summary (Sep 2022): https://www.stockscans.in/company/BSE%3AGUJTHEM/transcript-notes/202209/9pprmt3npvjwsc7b6lxml9u2.pdf